Exploring lithium's transcriptional mechanisms of action in bipolar disorder: a multi-step study.

ABSTRACT: Lithium has been the first-line treatment for bipolar disorder (BD) for more than six decades. Although the molecular effects of lithium have been studied extensively and gene expression changes are generally believed to be involved, the specific mechanisms of action that mediate mood regulation are still not known. In this study, a multi-step approach was used to explore the transcriptional changes that may underlie lithium's therapeutic efficacy. First, we identified genes that are associated both with lithium exposure and with BD, and second, we performed differential expression analysis of these genes in brain tissue samples from BD patients (n?=?42) and healthy controls (n?=?42). To identify genes that are regulated by lithium exposure, we used high-sensitivity RNA-sequencing of corpus callosum (CC) tissue samples from lithium-treated (n?=?8) and non-treated (n?=?9) rats. We found that lithium exposure significantly affected 1108 genes (FDR?

SUBMITTER: Akkouh IA 

PROVIDER: S-EPMC7162887 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature